EP 1603575 A2 20051214 - NEMORUBICIN AS RADIOSENSITIZER IN COMBINATION WITH RADIATION THERAPY AGAINST TUMORS
Title (en)
NEMORUBICIN AS RADIOSENSITIZER IN COMBINATION WITH RADIATION THERAPY AGAINST TUMORS
Title (de)
NEMORUBICIN ALS STRAHLUNGSSENSIBILISATOR ZUSAMMEN MIT STRAHLENTHERAPIE GEGEN KREBS
Title (fr)
POLYTHERAPIE CONTRE DES TUMEURS COMPRENANT L'ADMINISTRATION DE NEMORUBICINE COMBINEE A UNE RADIOTHERAPIE
Publication
Application
Priority
- EP 2004050246 W 20040303
- EP 03075781 A 20030318
- EP 04716607 A 20040303
Abstract (en)
[origin: WO2004082579A2] The present invention relates to a morpholinyl anthracycline derivative for use as radiosensitizer, to be administered in combination with radiation therapy, so that a synergistic effect can be revealed.
IPC 1-7
IPC 8 full level
A61K 31/282 (2006.01); A61K 31/704 (2006.01); A61K 33/24 (2006.01); A61K 33/243 (2019.01); A61K 41/00 (2006.01); A61K 45/06 (2006.01); A61P 35/00 (2006.01)
CPC (source: EP US)
A61K 31/282 (2013.01 - EP); A61K 31/704 (2013.01 - EP); A61K 33/243 (2018.12 - EP US); A61K 41/00 (2013.01 - EP); A61K 45/06 (2013.01 - EP); A61P 35/00 (2017.12 - EP)
Citation (search report)
See references of WO 2004082579A2
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2004082579 A2 20040930; WO 2004082579 A3 20041111; AU 2004222526 A1 20040930; BR PI0408494 A 20060404; CA 2519289 A1 20040930; EP 1603575 A2 20051214; MX PA05009851 A 20051206; NO 20054349 L 20051011; RU 2005132175 A 20060127
DOCDB simple family (application)
EP 2004050246 W 20040303; AU 2004222526 A 20040303; BR PI0408494 A 20040303; CA 2519289 A 20040303; EP 04716607 A 20040303; MX PA05009851 A 20040303; NO 20054349 A 20050920; RU 2005132175 A 20040303